Skip to Main Content

Author Details

Jason A Sprowl
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
2007
30
20
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36352830Comparison of P-glycoprotein function in peripheral blood mononuclear cells ex vivo in stable Black and White male and female kidney transplant recipients.Clin Transl Sci2023
35390174Regulation of Drug Transport Proteins-From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium.Clin Pharmacol Ther2022
35383108Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake.Mol Pharmacol2022
35546260Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4.Clin Pharmacol Ther2022
34330821Current Understanding of Membrane Transporters as Regulators or Targets for Cisplatin-Induced Hearing Loss.Mol Pharmacol2021
33664059Regulation of OATP1B1 Function by Tyrosine Kinase-mediated Phosphorylation.Clin Cancer Res2021
32484793Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice.J Clin Invest2020
29337310OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.J Clin Invest2018
30028006Strategies to Reduce Solute Carrier-Mediated Toxicity.Clin Pharmacol Ther2018
29756222Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.Clin Pharmacol Ther2018
28689374Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity.Clin Transl Sci2017
26979622A phosphotyrosine switch regulates organic cation transporters.Nat Commun2016
25823781Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.Pharmacogenomics2015
25848011Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions.Proc Natl Acad Sci U S A2015
24378324Uptake carriers and oncology drug safety.Drug Metab Dispos2014
24916697Cisplatin-induced renal injury is independently mediated by OCT2 and p53.Clin Cancer Res2014
22986709Polymorphic transporters and platinum pharmacodynamics.Drug Metab Pharmacokinet2013
23863876Conjunctive therapy of cisplatin with the OCT2 inhibitor cimetidine: influence on antitumor efficacy and systemic clearance.Clin Pharmacol Ther2013
23960178Can erlotinib ameliorate cisplatin-induced toxicities?J Clin Oncol2013
23640974CYP3A4*22 genotype and systemic exposure affect paclitaxel-induced neurotoxicity.Clin Cancer Res2013
23776246Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2.Proc Natl Acad Sci U S A2013
23757163Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics.Mol Cancer Ther2013
22223530Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients.Clin Cancer Res2012
22938713Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization.BMC Cancer2012
23085872Drug trafficking: recent advances in therapeutics and disease.Clin Pharmacol Ther2012
22534871Associations between ABCC2 polymorphisms and cisplatin disposition and efficacy.Clin Pharmacol Ther2012
22459901Contribution of tumoral and host solute carriers to clinical drug response.Drug Resist Updat2012
22225778Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells.Breast Cancer Res2012
20125118The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance.Pharmacogenomics J2010
17512223Changes in expression of cell wall turnover genes accompany inhibition of chromosome segregation by bovine protein kinase C alpha expression in Saccharomyces cerevisiae.Cell Biol Int2007
  • 1 - 30 of 30

Recommended Authors

Xiaomin Liang
Gilead Sciences Inc.
Career Start Year 2014
Number of shared co-authors 3
Xun Bao
Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute
Career Start Year 2014
Number of shared co-authors 1
Iris Chiara Salaroglio
University of Turin
Career Start Year 2013
Number of shared co-authors 0
Eugene C Chen
Department of Drug Metabolism and Pharmacokinetics, Inc.
Career Start Year 2010
Number of shared co-authors 3
Arik A Zur
Schools of Pharmacy and Medicine, University of California san francisco
Career Start Year 2009
Number of shared co-authors 3
Lawrence Lin
University of California San Francisco
Career Start Year 2009
Number of shared co-authors 3
Bo Gao
Crown Princess Mary Cancer Centre, Westmead Hospital
Career Start Year 2008
Number of shared co-authors 2
Natalia Khuri
Stanford University
Career Start Year 2007
Number of shared co-authors 3
Ahmed Aman
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2007
Number of shared co-authors 0
Kari M Morrissey
Amunix Pharmaceuticals
Career Start Year 2006
Number of shared co-authors 2
Ligong Chen
Tsinghua University
Career Start Year 2006
Number of shared co-authors 2
P??r Matsson
University of Gothenburg
Career Start Year 2005
Number of shared co-authors 2
Leslie W Chinn
Genentech Inc.
Career Start Year 2003
Number of shared co-authors 1
Sook Wah Yee
University of California San Francisco
Career Start Year 2001
Number of shared co-authors 6
Cristina Rodr??guez-Antona
Spanish National Cancer Research Center (CNIO)
Career Start Year 2000
Number of shared co-authors 1
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 2
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year 1998
Number of shared co-authors 0
Sunil Sharma
Brody School of Medicine, East Carolina University
Career Start Year 1997
Number of shared co-authors 1
David de Graaf
Syntimmune Inc.
Career Start Year 1995
Number of shared co-authors 0
Deanna L Kroetz
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 5
Mark J Ratain
University of Chicago
Career Start Year 1985
Number of shared co-authors 5
Chiara Riganti
University of Turin
Career Start Year 1985
Number of shared co-authors 0
Per Artursson
Department of Pharmacy, Uppsala University
Career Start Year 1983
Number of shared co-authors 4
Mary Eileen Dolan
University of Chicago
Career Start Year 1981
Number of shared co-authors 5
Howard L McLeod
Center for Precision Medicine and Functional Genomics, Utah Tech University
Career Start Year 1979
Number of shared co-authors 10
Kathleen M Giacomini
University of California San Francisco
Career Start Year 1978
Number of shared co-authors 8
Anne Monks
Institute of Biomedical Engineering (IBME), University of Oxford
Career Start Year 1976
Number of shared co-authors 0
Paul Workman
The Institute of Cancer Research
Career Start Year 1974
Number of shared co-authors 1
Stephen B Howell
Moores Cancer Center and Department of Medicine, University of California
Career Start Year 1974
Number of shared co-authors 1
James H Doroshow
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 3

Collaborators

Alex Sparreboom
Ohio State University
Co-authored papers 20
Shuiying Hu
The Ohio State University
Co-authored papers 12
Alice A Gibson
The Ohio State University
Co-authored papers 11
Giuliano Ciarimboli
University Hospital Munster
Co-authored papers 7
Eberhard Schlatter
University Hospital Muenster
Co-authored papers 6
Navjotsingh Pabla
The Ohio State University
Co-authored papers 5
Lie Li
Sino-French Hoffmann Institute, Guangzhou Medical University
Co-authored papers 5
Guido Cavaletti
NeuroMI (Milan Center for Neuroscience)
Co-authored papers 4
Su Sien Ong
St. Jude Children's Research Hospital
Co-authored papers 3
Guoqing Du
Second Affiliated Hospital of Harbin Medical University
Co-authored papers 3
Taosheng Chen
St. Jude Children's Research Hospital
Co-authored papers 3
Jan H M Schellens
Department of Pharmaceutical Sciences, Utrecht University
Co-authored papers 2
Aksana Vasilyeva
St Jude Children's Research Hospital
Co-authored papers 2
Rachel A Ness
4Department of Pharmacy, Memphis Veterans Affairs Medical Center
Co-authored papers 2
Sharyn D Baker
Ohio State University
Co-authored papers 2
Irina Kalatskaya
EMD Serono Research & Development Institute, Inc. (an affiliate of Merck KGaA)
Co-authored papers 1
Lara E Sucheston-Campbell
The Ohio State University
Co-authored papers 1
Hermann Pavenstädt
Co-authored papers 1
Shashank Bharill
University of California berkeley
Co-authored papers 1
Robert B Diasio
Mayo Clinic
Co-authored papers 1
Mary V Relling
Departments of Pharmaceutical Sciences.
Co-authored papers 1
Daniel A Brazeau
Marshall University, Joan C. Edwards School of Medicine
Co-authored papers 1
Ehud Y Isacoff
University of California berkeley
Co-authored papers 1
Anne T Nies
and University of Tuebingen, University of Tuebingen
Co-authored papers 1
Ching-Hon Pui
St. Jude Children's Research Hospital
Co-authored papers 1
Lincoln Stein
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 1
Charles L Loprinzi
Mayo Clinic
Co-authored papers 1
Matthias Schwab
and of Biochemistry and Pharmacy, University of Tuebingen
Co-authored papers 1
Wenwei Lin
St. Jude Children's Research Hospital
Co-authored papers 1
Adrian Stecula
Schools of Pharmacy and Medicine, University of California san francisco
Co-authored papers 1
Release 1.2